The structure of gastrointestinal tract pathology in patients receiving hemodialysis treatment

BACKGROUND. Hemodialysis patients are characterized by a wide range of concomitant diseases, including cardiovascular, bone mineral, nutritional, cognitive, various metabolic disorders and anemia. Meanwhile, gastrointestinal tract disorders in these patients remains largely unexplored. Patients receiving treatment with programmed hemodialysis are characterized by a wide range of concomitant diseases, including cardiovascular, bone mineral, nutritional, cognitive, various metabolic disorders and anemia. Meanwhile, the pathology of the gastrointestinal tract in this category of patients remains largely unexplored.

AIM: to investigate the structure of digestive diseases in patients receiving hemodialysis treatment.

PATIENTS AND METHODS. This study included 180 hemodialysis patients. The median age was 60[47;68] years. Gastrointestinal Symptoms Questionnaire (GSQ) was used to evaluate gastrointestinal symptoms over the last month. The results of abdomen ultrasound, gastroscopy, colonoscopy, and complex laboratory examination were also analyzed.

RESULTS. The overall prevalence of gastrointestinal symptoms was 77.2 % (139/180). The most frequent complaints were constipation (46.8 %) and abdominal pain (41 %). The most common stool frequency was one bowel action per day. The third, fourth, fifth type of stool according to the Bristol Stool Form Scale were noted by the majority of participants. Abdominal ultrasound revealed diffuse liver changes in 115 (63.9 %), signs of cirrhosis – in 7(3.9 %) patients. Ultrasound pathology of the gallbladder was represented by anomalies of its shape in 11.1 %, signs of chronic cholecystitis – in 10 %, stones (sludge) – in 7.2 %, polyps – in 2.2 % of patients. Diffuse changes in pancreatic parenchyma, steatosis, pseudocysts and dilatation of the main pancreatic duct were diagnosed respectively in 39(21,7 %), 21(11,7 %), 10(5,6 %) and 3(1.7 %) hemodialysis patients. According to 154 gastroscopies, the most common endoscopic finding in the stomach was chronic gastritis, detected in 86(55.8 %) of the subjects. Erosive gastritis was diagnosed in 22(14.3 %), gastric ulcer – in 3(2.0 %) patients. Endoscopic duodenal pathology was represented by erythematous duodenitis in 53(34.4 %), erosive duodenitis in 15(9.7 %), ulcer in 2(1.3 %), duodenal bulb abnormalities in 23(14.9 %) patients. Combined gastric and duodenal lesions were found in 88(57.1 %) patients. Сolonoscopy was performed in 56 patients, of whom 15 (26.8 %) had signs of colitis (mainly sigmoiditis), 2(3.6 %) – diverticulitis, 10(17.9 %) – diverticulosis, 12(21.4 %) – colon polyps, 8(14.3 %) – angiodysplasia mucosa, in 3(5.4 %) – dolichocolon. Despite the abundance of gastrointestinal symptoms and instrumental findings, no significant deviations in laboratory parameters (including an increase in AST, ALT, total bilirubin, amylase, lipase) were found.

CONCLUSION. Hemodialysis patients are characterized by a high prevalence of gastrointestinal symptoms and various pathological changes in the gastrointestinal tract, the diagnosis and treatment of which require an individual multidisciplinary approach.

1. Jager K, Kovesdy C, Langham R et al. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Nephrology, dialysis, trans-plantation 2019;34(11):1803–1805. https://doi.org/10.1093/ndt/gfz174

2. Costa-Moreira P, Vilas-Boas F, Teixeira Fraga A, Macedo G. Particular aspects of gastroenterological disorders in chronic kidney disease and end-stage renal disease patients: a clini-cally focused review. Scand J Gastroenterol 2020;55(2):129–138. https://doi.org/10.1080/00365521.2020.1722217

3. Rocco M, Gassman J, Wang S, Kaplan R. Cross-sectional study of quality of life and symptoms in chronic renal disease patients: the Modification of Diet in Renal Disease Study. Am J Kidney Dis 1997;29(6):888–896. https://doi.org/10.1016/s0272-6386(97)90463-7

4. Chong V. Impact of duration of hemodialysis on gastro-intestinal symptoms in patients with end stage renal failure. J Gastrointestin Liver Dis 2010;19(4):462–463

5. Lee Y, Hung S, Wang H et al. Different Risk of Common Gastrointestinal Disease Between Groups Undergoing Hemo-dialysis or Peritoneal Dialysis or With Non-End Stage Renal Disease: A Nationwide Population-Based Cohort Study. Medi-cine (Baltimore) 2015;94(36):e1482. https://doi.org/10.1097/MD.0000000000001482

6. Shirazian S, Radhakrishnan J. Gastrointestinal disorders and renal failure: exploring the connection. Nat Rev Nephrol 2010;6(8):480–492. https://doi.org/10.1038/nrneph.2010.84

7. Ryss ES, Lutoshkin MB. Active methods of chronic renal failure treatment and upper gastrointestinal tract pathology (clinical endoscopic studies). Nephrology (Saint-Petersburg) 1997;1(1):27–32. (In Russ.) ht tps://doi.org/10.24884/1561-6274-1997-1-1-27-32

8. Dong R, Guo ZY, Ding JR et al. Gastrointestinal symptoms: a comparison between patients undergoing peritoneal dialysis and hemodialysis. World J Gastroenterol 2014;20(32):11370–11375. https://doi.org/10.3748/wjg.v20.i32.11370

9. Bossola M, Tazza L, Giungi S, Luciani G. Anorexia in he-modialysis patients: an update. Kidney Int 2006;70(3):417–422. https://doi.org/10.1038/sj.ki.5001572

10. Carrero JJ, Aguilera A, Stenvinkel P et al. Appetite dis-orders in uremia. J Ren Nutr 2008;18(1):107–113. https://doi.org/10.1053/j.jrn.2007.10.022

11. Bossola M, Luciani G, Rosa F, Tazza L. Appetite and gas-trointestinal symptoms in chronic hemodialysis patients. J Ren Nutr 2011;21(6):448–454. https://doi.org/10.1053/j.jrn.2010.09.003

12. Zuvela J, Trimingham C, Le Leu R et al. Gastrointestinal symptoms in patients receiving dialysis: A systematic review. Ne-phrology (Carlton) 2018;23(8):718–727. https://doi.org/10.1111/nep.13243

13. Ruszkowski J, Majkutewicz K, Heleniak Z et al. Prevalence and Severity of Lower Gastrointestinal Symptoms amongst Non-Dialysis Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis. J Clin Med 2022;11(21):6363. https://doi.org/10.3390/jcm11216363

14. Strid H, Simrén M, Johansson A et al. The prevalence of gastrointestinal symptoms in patients with chronic renal failure is increased and associated with impaired psychological general well-being. Nephrol Dial Transplant 2002;17(8):1434–1439. https://doi.org/10.1093/ndt/17.8.1434

15. Katalinic L, Premuzic V, Basic-Jukic N et al. Hypopro-teinemia as a factor in assessing malnutrition and predicting survival on hemodialysis. J Artif Organs 2019;22(3):230–236. https://doi.org/10.1007/s10047-019-01098-3

16. Peery AF, Crockett SD, Murphy CC et al. Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021. Gastroenterology 2022;162(2):621–644. https://doi.org/10.1053/j.gastro.2021.10.017

17. Pyatchenkov MO, Markov AG, Rumyantsev AS. Structural and functional intestinal barrier abnormalities and chronic kidney disease. Literature review. Part I. Nephrology (Saint-Petersburg) 2022;26(1):10–26. (In Russ.) https://doi.org/10.36485/1561-6274-2022-26-1-10-26

18. Pyatchenkov MO, Rumyantsev AS, Sherbakov EV, Mar-kov AG. Structural and functional intestinal barrier abnormalities and chronic kidney disease. Literature review. Part II. Nephrol-ogy (Saint-Petersburg) 2022;26(2):46–64. (In Russ.) https://doi.org/10.36485/1561-6274-2022-26-2-46-64

19. De Schoenmakere G, Vanholder R, Rottey S et al. Rela-tionship between gastric emptying and clinical and biochemical factors in chronic haemodialysis patients. Nephrol Dial Transplant 2001;16(9):1850–1855. ht tps://doi.org/10.1093/ndt/16.9.1850

20. Hubalewska A, Stompór T, Płaczkiewicz E et al. Evaluation of gastric emptying in patients with chronic renal failure on continu-ous ambulatory peritoneal dialysis using 99mTc-solid meal. Nucl Med Rev Cent East Eur 2004;7(1):27–30

21. Strid H, Simrén M, Stotzer PO et al. Delay in gastric emptying in patients with chronic renal failure. Scand J Gastro-enterol 2004;39(6):516–520. https://doi.org/10.1080/00365520410004505

22. Chong VH, Tan J. Prevalence of gastrointestinal and psy-chosomatic symptoms among Asian patients undergoing regular hemodialysis. Nephrology (Carlton) 2013;18(2):97–103. https://doi.org/10.1111/nep.12000

23. Locke GR 3rd, Zinsmeister AR, Fett SL et al. Overlap of gastrointestinal symptom complexes in a US community. Neuro-gastroenterol Motil 2005;17(1):29–34. https://doi.org/10.1111/j.1365-2982.2004.00581.x

24. Salmoirago-Blotcher E, Crawford S, Jackson E et al. Constipation and risk of cardiovascular disease among post-menopausal women. Am J Med 2011;124(8):714–723. https://doi.org/10.1016/j.amjmed.2011.03.026

25. Kubota Y, Iso H, Tamakoshi A. Bowel Movement Frequency, Laxative Use, and Mortality From Coronary Heart Disease and Stroke Among Japanese Men and Women: The Japan Collaborative Cohort (JACC) Study. J Epidemiol 2016;26(5):242–248. https://doi.org/10.2188/jea.JE20150123

26. Sumida K, Molnar MZ, Potukuchi PK et al. Constipation and Incident CKD. J Am Soc Nephrol 2017;28(4):1248–1258. https://doi.org/10.1681/ASN.2016060656

27. Garrow D, Delegge MH. Risk factors for gastrointestinal ulcer disease in the US population. Dig Dis Sci 2010;55(1):66–72. https://doi.org/10.1007/s10620-008-0708-x

28. Kang JY, Wu AY, Sutherland IH, Vathsala A. Prevalence of peptic ulcer in patients undergoing maintenance hemodi-alysis. Dig Dis Sci 1988;33(7):774–778. https://doi.org/10.1007/BF01550962

29. El Ghonaimy E, Barsoum R, Soliman M et al. Serum gastrin in chronic renal failure: morphological and physi-ological correlations. Nephron 1985;39(2):86–94. https://doi.org/10.1159/000183350

30. Paronen I, Ala-Kaila K, Rantala I et al. Gastric parietal, chief, and G-cell densities in chronic renal failure. Scand J Gastro-enterol 1991;26(7):696–700. https://doi.org/10.3109/00365529108998586

31. Khedmat H, Ahmadzad-Asl M, Amini M et al. Gastro-duo-denal lesions and Helicobacter pylori infection in uremic patients and renal transplant recipients. Transplant Proc 2007;39(4):1003– 1007. https://doi.org/10.1016/j.transproceed.2007.03.034

32. Lanza FL, Chan FK, Quigley EM. Practice Parameters Committee of the American College of Gastroenterology. Guide-lines for prevention of NSAID-related ulcer complications. Am J Gastroenterol 2009;104(3):728–738. https://doi.org/10.1038/ajg.2009.115

33. Chang SS, Hu HY. Lower Helicobacter pylori infection rate in chronic kidney disease and end-stage renal disease patients with peptic ulcer disease. J Chin Med Assoc 2014;77(7):354–359. https://doi.org/10.1016/j.jcma.2014.04.004

34. Shin SP, Bang CS, Lee JJ, Baik GH. Helicobacter pylori Infection in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Gut Liver 2019;13(6):628–641. https://doi.org/10.5009/gnl18517

35. Sugimoto M, Sakai K, Kita M et al. Prevalence of Helico-bacter pylori infection in long-term hemodialysis patients. Kidney Int 2009;75(1):96–103. https://doi.org/10.1038/ki.2008.508

36. Luo JC, Leu HB, Hou MC et al. Nonpeptic ulcer, non-variceal gastrointestinal bleeding in hemodialysis patients. Am J Med 2013;126(3):264.e25–32. https://doi.org/10.1016/j.amjmed.2012.09.010

37. Chalasani N, Cotsonis G, Wilcox CM. Upper gastrointes-tinal bleeding in patients with chronic renal failure: role of vascular ectasia. Am J Gastroenterol 1996;91(11):2329–2332

38. Tudor S, Dima B, Herlea V et al. Angiodisplazie colonică asociată cu insuficientăi renală cronică [Colonic angiodysplasia in a chronic renal failure patient]. Chirurgia (Bucur) 2006;101(6):629– 631

39. Ak mal M, Sawelson S, Karubian F, Gadallah M. The prevalence and significance of occult blood loss in patients with predialysis advanced chronic renal failure (CRF), or receiving dialytic therapy. Clin Nephrol 1994;42(3):198–202

40. Sood P, Kumar G, Nanchal R et al Chronic kidney disease and end-stage renal disease predict higher risk of mortality in pa-tients with primary upper gastrointestinal bleeding. Am J Nephrol 2012;35(3):216–224. https://doi.org/10.1159/000336107

41. Cheung J, Yu A, LaBossiere J et al. Peptic ulcer bleeding outcomes adversely affected by end-stage renal disease. Gas-trointest Endosc 2010;71(1):44–49. https://doi.org/10.1016/j.gie.2009.04.014

42. Rockall TA, Logan RF, Devlin HB, Northfield TC. Risk as-sessment after acute upper gastrointestinal haemorrhage. Gut 38(3):316–321. https://doi.org/10.1136/gut.38.3.316

43. Parasa S, Navaneethan U, Sridhar AR et al. End-stage renal disease is associated with worse outcomes in hospital-ized patients with peptic ulcer bleeding. Gastrointest Endosc 2013;77(4):609–616. https://doi.org/10.1016/j.gie.2012.11.014

44. Kalman RS, Pedrosa MC. Evidence-based review of gastrointestinal bleeding in the chronic kidney disease patient. Semin Dial 2015;28(1):68–74. https://doi.org/10.1111/sdi.12301

45. Grant CJ, Harrison LE, Hoad CL et al. Patients with chronic kidney disease have abnormal upper gastro-intestinal tract di-gestive function: A study of uremic enteropathy. J Gastroenterol Hepatol 2017;32(2):372–377. https://doi.org/10.1111/jgh.13458

46. Ohmori T, Konishi H, Nakamura S, Shiratori K. Abnormali-ties of the small intestine detected by capsule endoscopy in he-modialysis patients. Intern Med 2012;51(12):1455–1460. https://doi.org/10.2169/internalmedicine.51.7190

47. Hosoe N, Matsukawa S, Kanno Y et al. Cross-sectional small intestinal surveillance of maintenance hemodialysis patients using video capsule endoscopy: SCHEMA study. Endosc Int Open 2016;4(5):E589–596. https://doi.org/10.1055/s-0042-105203

48. Bini EJ, Kinkhabwala A, Goldfarb DS. Predictive value of a positive fecal occult blood test increases as the severity of CKD worsens. Am J Kidney Dis 2006;48(4):580–586. https://doi.org/10.1053/j.ajkd.2006.07.002

49. Chang SS, Huang N, Hu HY. Patients with end-stage re-nal disease were at an increased risk of hospitalization for acute diverticulitis. Medicine (Baltimore) 2016;95(39):e4881. https://doi.org/10.1097/MD.0000000000004881

50. Duarte-Chavez R, Stoltzfus J, Yellapu V et al. Colonic diverticular disease in autosomal dominant polycystic kidney disease: is there really an association? A nationwide analysis. Int J Colorectal Dis 2021;36(1):83–91. https://doi.org/10.1007/s00384-020-03736-2

51. Scheff RT, Zuckerman G, Harter H et al. Diverticular dis-ease in patients with chronic renal failure due to polycystic kidney disease. Ann Intern Med 1980;92(2 Pt 1):202–204. https://doi.org/10.7326/0003-4819-92-2-202

52. Foutch PG. Colonic angiodysplasia. Gastroenterologist 1997;5(2):148–156

53. Poralla T. Angiodysplasia in the renal patient: how to diag-nose and how to treat? Nephrol Dial Transplant 1998;13(9):2188– 2191. https://doi.org/10.1093/ndt/13.9.2188

54. Gupta N, Longo WE, Vernava AM 3rd. Angiodysplasia of the lower gastrointestinal tract: an entity readily diagnosed by colo-noscopy and primarily managed nonoperatively. Dis Colon Rectum 1995;38(9):979–982. https://doi.org/10.1007/BF02049736

55. Alvarez L, Puleo J, Balint JA. Investigation of gastroin-testinal bleeding in patients with end stage renal disease. Am J Gastroenterol 1993;88(1):30–33

56. Flobert C, Cellier C, Berger A et al. Right colonic involve-ment is associated with severe forms of ischemic colitis and occurs frequently in patients with chronic renal failure requiring hemodialysis. Am J Gastroenterol 2000;95(1):195–198. https://doi.org/10.1111/j.1572-0241.2000.01644.x

57. Li SY, Chen YT, Chen TJ et al. Mesenteric ischemia in patients with end-stage renal disease: a nationwide longitu-dinal study. Am J Nephrol 2012;35(6):491–497. https://doi.org/10.1159/000338451

58. Ori Y, Chagnac A, Schwartz A et al. Non-occlusive mes-enteric ischemia in chronically dialyzed patients: a disease with multiple risk factors. Nephron Clin Pract 2005;101(2):c87–93. https://doi.org/10.1159/000086346

59. Seong EY, Zheng Y, Winkelmayer WC et al. The Relation-ship between Intradialytic Hypotension and Hospitalized Mes-enteric Ischemia: A Case-Control Study. Clin J Am Soc Nephrol 2018;13(10):1517–1525. https://doi.org/10.2215/CJN.13891217

60. Archodovassilis F, Lagoudiannakis EE, Tsekouras DK et al. Nonocclusive mesenteric ischemia: a lethal complication in peritoneal dialysis patients. Perit Dial Int 2007;27(2):136–141

61. Newman LA, Mittman N, Hunt Z, Alfonso AE. Survival among chronic renal failure patients requiring major abdominal surgery. J Am Coll Surg 1999;188(3):310–314. https://doi.org/10.1016/s1072-7515(98)00308-1

62. Picazo M, Cuxart M, Sans R et al. Isquemia mesentérica en pacientes en hemodiálisis [Mesenteric ischemia in hemodialysis patients]. Nefrologia 2008;28(2):198–202

63. Wootton FT, Rhodes DF, Lee WM, Fitts CT. Colonic necrosis with Kayexalate-sorbitol enemas after renal transplantation. Ann In-tern Med 1989;111(11):947–949. https://doi.org/10.7326/0003-4819-111-11-947

64. Bischel MD, Reese T, Engel J. Spontaneous perforation of the colon in a hemodialysis patient. Am J Gastroenterol 1980; 74(2):182–184

65. Lillemoe KD, Romolo JL, Hamilton SR et al. Intestinal ne-crosis due to sodium polystyrene (Kayexalate) in sorbitol enemas: clinical and experimental support for the hypothesis. Surgery 1987;101(3):267–272

66. Harel Z, Harel S, Shah PS et al. Gastrointestinal adverse events with sodium polystyrene sulfonate (Kayexalate) use: a systematic review. Am J Med 2013;126(3):264.e9–24. https://doi.org/10.1016/j.amjmed.2012.08.016

67. Rashid A, Hamilton SR. Necrosis of the gastrointestinal tract in uremic patients as a result of sodium polystyrene sulfonate (Kayexalate) in sorbitol: an underrecognized condition. Am J Surg Pathol 1997;21(1):60–69. https://doi.org/10.1097/00000478-199701000-00007

68. Pyatchenkov MO, Salikova SP, Sherbakov EV, Vlasov AA. The state of the intestinal microbial-tissue complex in patients with chronic kidney disease. Bulletin of the Russian Military Medical Academy 2023;25(1):155–164. (In Russ.)] https://doi.org/10.17816/brmma124822

69. Morelli MC, Rendina M, La Manna G et al. Italian Associa-tion for the Study of Liver, and the Italian Society of Nephrology. Position paper on liver and kidney diseases from the Italian As-sociation for the Study of Liver (AISF), in collaboration with the Italian Society of Nephrology (SIN). Dig Liver Dis 2021 Jun;53 Suppl 2:S49–S86. https://doi.org/10.1016/j.dld.2021.03.035

70. Dobronravov VA, Dunaeva NV. Renal damage and chronic hepatitis C virus. Nephrology (Saint-Petersburg) 2008;12(4):9–19 (In Russ.) https://doi.org/10.24884/1561-6274-2008-12-4-9-19

71. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Phar-macol Ther 2011;34(3):274–285. https://doi.org/10.1111/j.1365-2036.2011.04724.x

72. Tilg H, Adolph TE, Moschen AR. Multiple Parallel Hits Hy-pothesis in Nonalcoholic Fatty Liver Disease: Revisited After a De-cade. Hepatology 2021;73(2):833–842. https://doi.org/10.1002/hep.31518

73. Mantovani A, Petracca G, Beatrice G et al. Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis. Gut 2022;71(1):156–162. https://doi.org/10.1136/gutjnl-2020-323082

74. Jin K, Norris K, Vaziri ND. Dysregulation of hepatic fatty acid metabolism in chronic kidney disease. Nephrol Dial Transplant 2013;28(2):313–320. https://doi.org/10.1093/ndt/gfs350

75. Yılmaz Ü, İnci A, Özcan E et al. Gallbladder Stone Preva-lence and Related Factors in Predialysis Chronic Kidney Disease Patients. Turk J Gastroenterol 2022;33(9):760–766. https://doi.org/10.5152/tjg.2022.22350

76. Dobosz Ł, Kobiela J, Danielewicz R et al. Gallbladder Pathologies in Kidney Transplant Recipients: Single-Center Experi-ence and a Review of the Literature. Ann Transplant 2018;23:572– 576. https://doi.org/10.12659/AOT.909653

77. Lankisch PG, Weber-Dany B, Maisonneuve P, Lowen-fels AB. Frequency and severity of acute pancreatitis in chronic dialysis patients. Nephrol Dial Transplant 2008;23(4):1401–1405. https://doi.org/10.1093/ndt/gfm769

78. Kroner PT, Mareth K, Raimondo M et al. Acute Pancreatitis in Advanced Chronic Kidney Disease and Kidney Transplant Recipi-ents: Results of a US Nationwide Analysis. Mayo Clin Proc Innov Qual Outcomes 2019;3(2):160–168. https://doi.org/10.1016/j.mayocpiqo.2019.03.006

79. Bruno MJ, van Westerloo DJ, van Dorp WT et al. Acute pancreatitis in peritoneal dialysis and haemodialysis: risk, clinical course, outcome, and possible aetiology. Gut 2000;46(3):385– 389. h ttps://doi.org/10.1136/gut.46.3.385

80. Gupta A, Yuan ZY, Balaskas EV et al. CAPD and pancreatitis: no connection. Perit Dial Int 1992;12(3):309–316

81. Royse VL, Jensen DM, Corwin HL. Pancreatic enzymes in chronic renal failure. Arch Intern Med 1987;147(3):537–539

82. Shibasaki T, Matsuda H, Ohno I et al Significance of serum lipase in patients undergoing hemodialysis. Am J Nephrol 1996;16(4):309–314. https://doi.org/10.1159/000169015

83. Schoenicke G, Grabensee B, Plum J. Dialysis with icodex-trin interferes with measurement of serum alpha-amylase activity. Nephrol Dial Transplant 2002;17(11):1988–1992. https://doi.org/10.1093/ndt/17.11.1988